Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MC Stock Summary
Top 10 Correlated ETFs
MC
In the News
Moelis & Company (MC) Incurs Loss in Q4, Revenues Rise Y/Y
A drastic increase in expenses hurts Moelis & Company's (MC) Q4 results, while higher revenues support some support.
Moelis & Company (MC) Q4 2023 Earnings Conference Call Transcript
Moelis & Company (MC) Q4 2023 Earnings Conference Call Transcript
Moelis (MC) Reports Q4 Loss, Tops Revenue Estimates
Moelis (MC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.33 per share a year ago.
Earnings Preview: Moelis (MC) Q4 Earnings Expected to Decline
Moelis (MC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moelis & Company to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on February 7, 2024
NEW YORK--(BUSINESS WIRE)-- #Moelis--Moelis & Company to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on February 7, 2024.
Ken Moelis Isn't Stepping Back
Six years ago, Ken Moelis predicted he would hand the reins of his namesake firm to someone else by the time he turned 65. That birthday came and went in July.
Moelis & Company (MC) Stock Slips 2% on Q3 Loss, Revenues Up
Higher operating expenses lead Moelis & Company (MC) to incur a loss in Q3. On the other hand, an increase in revenues offers some support.
Moelis & Company (MC) Q3 2023 Earnings Conference Call Transcript
Moelis & Company (NYSE:MC ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Matt Tsukroff - IR Joe Simon - CFO Ken Moelis - Chairman & CEO Conference Call Participants Devin Ryan - JMP Securities Ken Worthington - JP Morgan James Yaro - Goldman Sachs Brendan O'Brien - Wolfe Research Brennan Hawking - UBS Connell Schmitz - Morgan Stanley Operator Ladies and gentlemen, thank you for standing-by. My name is Sheryl.
Most of our expansion in the Middle East will be in Saudi Arabia, says Moelis & Company CEO
Ken Moelis, Moelis & Company CEO, discusses its expansion in the Middle East.
3 Shaky Stocks to Ditch Before November 2023
Understandably, the concept of stocks to sell is a controversial one in the capital market. Let me rephrase that in baseball terms.
MC Financial details
MC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.45 | 16.25 | 22.51 | 14.01 | 12.48 | |
Net income per share | 1.89 | 3.08 | 5.34 | 2.14 | -0.36 | |
Operating cash flow per share | 3.77 | 7.4 | 13.69 | 0.47 | 2.31 | |
Free cash flow per share | 3.65 | 6.7 | 13.45 | 0.38 | 2.07 | |
Cash per share | 3.02 | 3.49 | 7.6 | 2.94 | 5.1 | |
Book value per share | 7.98 | 8.27 | 7.15 | 6.32 | 5.14 | |
Tangible book value per share | 7.09 | 7.61 | 6.95 | 6.49 | 5.29 | |
Share holders equity per share | 7.98 | 8.27 | 7.15 | 6.32 | 5.14 | |
Interest debt per share | 3.85 | 3.72 | 3.14 | 3.23 | 3.45 | |
Market cap | 1.77B | 2.71B | 4.28B | 2.7B | 3.84B | |
Enterprise value | 1.8B | 2.71B | 3.95B | 2.68B | 3.87B | |
P/E ratio | 16.86 | 15.17 | 11.71 | 17.95 | -155.67 | |
Price to sales ratio | 2.37 | 2.88 | 2.78 | 2.74 | 4.5 | |
POCF ratio | 8.47 | 6.32 | 4.57 | 81.78 | 24.26 | |
PFCF ratio | 8.74 | 6.98 | 4.65 | 99.8 | 27.12 | |
P/B Ratio | 4 | 5.65 | 8.75 | 6.07 | 10.92 | |
PTB ratio | 4 | 5.65 | 8.75 | 6.07 | 10.92 | |
EV to sales | 2.41 | 2.87 | 2.56 | 2.72 | 4.53 | |
Enterprise value over EBITDA | 15.08 | 10.01 | 7.85 | 11.98 | -120.94 | |
EV to operating cash flow | 8.61 | 6.31 | 4.22 | 81.35 | 24.45 | |
EV to free cash flow | 8.88 | 6.97 | 4.29 | 99.28 | 27.33 | |
Earnings yield | 0.06 | 0.07 | 0.09 | 0.06 | -0.01 | |
Free cash flow yield | 0.11 | 0.14 | 0.22 | 0.01 | 0.04 | |
Debt to equity | 0.48 | 0.45 | 0.44 | 0.47 | 0.67 | |
Debt to assets | 0.2 | 0.18 | 0.14 | 0.17 | 0.2 | |
Net debt to EBITDA | 0.25 | -0.02 | -0.65 | -0.06 | -0.91 | |
Current ratio | 0.47 | 0.55 | 0.67 | 0.47 | 0.42 | |
Interest coverage | 0 | 0 | 0 | 11.93 | 0 | |
Income quality | 1.54 | 1.96 | 2.22 | 0.2 | -6.42 | |
Dividend Yield | 0.12 | 0.1 | 0.11 | 0.06 | 0.05 | |
Payout ratio | 1.99 | 1.58 | 1.31 | 1.16 | -7.37 | |
Sales general and administrative to revenue | 0.15 | 0.1 | 0.06 | 0.12 | 0.13 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.01 | |
Capex to operating cash flow | -0.03 | -0.09 | -0.02 | -0.18 | -0.11 | |
Capex to revenue | -0.01 | -0.04 | -0.01 | -0.01 | -0.02 | |
Capex to depreciation | -1.3 | -8.64 | -2.27 | -0.75 | -2.01 | |
Stock based compensation to revenue | 0.17 | 0.14 | 0.11 | 0.13 | 0.19 | |
Graham number | 18.43 | 23.95 | 29.29 | 17.44 | 6.46 | |
ROIC | 0.12 | 0.24 | 0.44 | 0.2 | -0.05 | |
Return on tangible assets | 0.1 | 0.15 | 0.24 | 0.12 | -0.02 | |
Graham Net | -6.41 | -5.53 | -3.06 | -7.24 | -4.77 | |
Working capital | -255.88M | -250.86M | -294.91M | -301.29M | -350.76M | |
Tangible asset value | 393.83M | 441.71M | 475.43M | 456.07M | 345.33M | |
Net current asset value | -453.5M | -447.47M | -486.8M | -494.05M | -566.45M | |
Invested capital | 0.48 | 0.45 | 0.44 | 0.47 | 0.67 | |
Average receivables | 62.2M | 78.5M | 85.39M | 62.95M | 59.99M | |
Average payables | 17.95M | 20.57M | 47.45M | 40.91M | 22.28M | |
Average inventory | 112.56M | 265.22M | 448.34M | 295.69M | 93.21M | |
Days sales outstanding | 27.28 | 39.16 | 16.48 | 20.87 | 27.17 | |
Days payables outstanding | 12.04 | 16.29 | 27.91 | 7.04 | 16.66 | |
Days of inventory on hand | 168.23 | 198.71 | 236.19 | 0 | 95.2 | |
Receivables turnover | 13.38 | 9.32 | 22.15 | 17.49 | 13.43 | |
Payables turnover | 30.32 | 22.41 | 13.08 | 51.82 | 21.91 | |
Inventory turnover | 2.17 | 1.84 | 1.55 | 0 | 3.83 | |
ROE | 0.24 | 0.37 | 0.75 | 0.34 | -0.07 | |
Capex per share | -0.12 | -0.7 | -0.24 | -0.08 | -0.24 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.94 | 2.63 | 2.7 | 4.08 | 3.12 | |
Net income per share | 0.28 | 0.05 | -0.18 | -0.16 | -0.08 | |
Operating cash flow per share | 1.74 | -2.13 | 1.07 | 2.1 | 1.44 | |
Free cash flow per share | 1.71 | -2.14 | 0.98 | 2.03 | 1.37 | |
Cash per share | 2.94 | 1.88 | 2.41 | 2.22 | 5.07 | |
Book value per share | 6.31 | 5.75 | 5.86 | 5.51 | 5.11 | |
Tangible book value per share | 6.48 | 6.03 | 5.68 | 5.68 | 5.26 | |
Share holders equity per share | 6.31 | 5.75 | 5.86 | 5.51 | 5.11 | |
Interest debt per share | 2.96 | 2.86 | 3.18 | 3.34 | 3.46 | |
Market cap | 2.7B | 2.75B | 3.02B | 3.01B | 3.87B | |
Enterprise value | 2.69B | 2.8B | 3.06B | 3.08B | 3.9B | |
P/E ratio | 33.68 | 187.33 | -63.02 | -70.09 | -170.77 | |
Price to sales ratio | 13.04 | 14.63 | 16.78 | 11.05 | 17.99 | |
POCF ratio | 22.07 | -18.06 | 42.42 | 21.47 | 38.92 | |
PFCF ratio | 22.45 | -17.93 | 46.03 | 22.22 | 41.11 | |
P/B Ratio | 6.08 | 6.68 | 7.74 | 8.2 | 10.98 | |
PTB ratio | 6.08 | 6.68 | 7.74 | 8.2 | 10.98 | |
EV to sales | 12.97 | 14.92 | 17.01 | 11.31 | 18.13 | |
Enterprise value over EBITDA | 85.05 | 4.11K | -399.93 | -414.07 | -552.17 | |
EV to operating cash flow | 21.96 | -18.42 | 43 | 21.96 | 39.22 | |
EV to free cash flow | 22.33 | -18.28 | 46.66 | 22.73 | 41.42 | |
Earnings yield | 0.01 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0.04 | -0.06 | 0.02 | 0.05 | 0.02 | |
Debt to equity | 0.47 | 0.5 | 0.54 | 0.61 | 0.67 | |
Debt to assets | 0.17 | 0.21 | 0.21 | 0.2 | 0.2 | |
Net debt to EBITDA | -0.44 | 80.59 | -5.35 | -9.24 | -4.15 | |
Current ratio | 0.47 | 0.5 | 0.52 | 0.37 | 0.42 | |
Interest coverage | -113.61 | 0.75 | 0 | 0 | -5.06 | |
Income quality | 5.4 | -42.7 | -5.37 | -13.06 | -17.55 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Payout ratio | 2.24 | 12.56 | -3.92 | -4.15 | -7.89 | |
Sales general and administrative to revenue | 0.14 | 0.17 | 0.14 | 0.05 | 0.13 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.03 | 0 | 0.01 | |
Capex to operating cash flow | -0.02 | 0.01 | -0.08 | -0.03 | -0.05 | |
Capex to revenue | -0.01 | -0.01 | -0.03 | -0.02 | -0.02 | |
Capex to depreciation | -0.93 | -0.53 | -2.88 | -2.35 | -2.3 | |
Stock based compensation to revenue | 0.16 | 0.32 | 0.19 | 0.12 | 0.15 | |
Graham number | 6.36 | 2.58 | 4.87 | 4.47 | 3.07 | |
ROIC | 0.02 | -0.02 | -0.01 | -0.03 | -0.02 | |
Return on tangible assets | 0.02 | 0 | -0.01 | -0.01 | 0 | |
Graham Net | -7.23 | -4.1 | -4.61 | -8.36 | -4.75 | |
Working capital | -301.29M | -182.99M | -198.58M | -328.76M | -350.76M | |
Tangible asset value | 456.07M | 430.59M | 377.92M | 378.82M | 345.33M | |
Net current asset value | -494.05M | -372.58M | -399.7M | -545.62M | -566.45M | |
Invested capital | 0.47 | 0.5 | 0.54 | 0.61 | 0.67 | |
Average receivables | 60.01M | 52.65M | 50.34M | 49.13M | 55.09M | |
Average payables | 9.47M | 20.58M | 28.21M | 27.54M | 30.26M | |
Average inventory | 0 | 92.55M | 199.13M | 106.58M | 93.21M | |
Days sales outstanding | 24.47 | 23.46 | 25.88 | 15.39 | 26.65 | |
Days payables outstanding | 7.61 | 17.75 | 16.78 | 10.06 | 16.45 | |
Days of inventory on hand | 0 | 112.38 | 131.58 | 0 | 94 | |
Receivables turnover | 3.68 | 3.84 | 3.48 | 5.85 | 3.38 | |
Payables turnover | 11.82 | 5.07 | 5.36 | 8.94 | 5.47 | |
Inventory turnover | 0 | 0.8 | 0.68 | 0 | 0.96 | |
ROE | 0.05 | 0.01 | -0.03 | -0.03 | -0.02 | |
Capex per share | -0.03 | -0.02 | -0.08 | -0.07 | -0.08 |
MC Frequently Asked Questions
What is Moelis & Company stock symbol ?
Moelis & Company is a US stock , located in New york of Ny and trading under the symbol MC
Is Moelis & Company buy or a sell ?
5 stock analysts have 5 predictions with a medium analyst target price of $42.6. The lowest prediction is $30 and the highest is $58
What is MC stock prediction ?
With a median analyst target price of $58, 1 stock analysts have made 1 forecasts in last 90 days. $58 is the lowest and $58 is the greatest projection.
What is Moelis & Company stock quote today ?
Moelis & Company stock price is $57.05 today.
Is Moelis & Company stock public?
Yes, Moelis & Company is a publicly traded company.